Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 584585
                    [Title] => AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management
                    [Summary] => 
Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall management of hypercholesterolemia.
                    [DatePublished] => 2010-06-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. PHILLIP BARTER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 584585
                    [Title] => AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management
                    [Summary] => 
Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall management of hypercholesterolemia.
                    [DatePublished] => 2010-06-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management

June 17, 2010 - 12:00am

Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall...

Science and Environment